Flu vaccines have prevented millions of deaths, research shows
Spanish flu pandemic was caused by a particularly virulent strain of influenza virus. It infected 500 million people, caused ...
Medscape6d
Immunogenicity and Safety of Inactivated Quadrivalent and Trivalent Influenza Vaccines in Children 18–47 Months of Age
Background Because inactivated trivalent influenza vaccines (TIVs) contain 1 influenza B strain, whereas 2 lineages may co-circulate, B lineage mismatch is frequent. We assessed an inactivated ...
Medscape4d
The Evolving History of Influenza Viruses and Influenza Vaccines
The isolation of influenza virus 80 years ago in 1933 very quickly led to the development of the first generation of live-attenuated vaccines. The first inactivated influenza vaccine was ...
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
Scientists Are Racing to Develop a New Bird Flu Vaccine
A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator. Around the same time, a senior in Louisiana was diagnosed with the first ...
Purdue University1d
Suresh Mittal presents ‘Universal Influenza Vaccine — An Aspiration or Reality?’ at Westwood Lecture Series
Suresh Mittal, Distinguished Professor of Virology in the College of Veterinary Medicine, presented “Universal Influenza Vaccine — An Aspiration or Reality?” at the Westwood Lecture Series on Jan. 28.
WBAL12d
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
AOL12d
Moderna awarded $590M to help accelerate development of mRNA-based bird flu vaccine: HHS
Moderna said the funding will support the expansion of clinical studies "for up to five additional subtypes of pandemic influenza ... a live-attenuated or inactivated vaccine.